AO ITC Clinical Science Advisory Commission
AO ITC Clinical Science Advisory Commission (CSAC) provides strategic advice for AO ITC in its clinical evidence generation and is an important body for innovation at AO ITC. The members of CSAC include experts from the clinical division of Trauma, CMF, and Spine. As of June 2022, a representative for AO VET is also added to the commission.
The purpose of the CSAC is elaborated by Michael Fehlings, the former chair of the CSAC, and Philip Louie in this interview.
Osama Farouk, MD
(Trauma Representative)
Prof of Orthopedic Surgery and
Chief of Orthopedic Trauma Unit,
Assiut University Hospitals, Egypt
Prof. Dr. Eppo Wolvius, MD, DDS, PhD
(CMF Representative)
Prof and Chair of Department of Oral and MaxFac Surgery, Erasmus University Medical Centre Rotterdam, Netherlands
Theodore Miclau, MD
(Chair)
Professor and Vice Chairman, Department of Orthopaedic Surgery, University of California, San Francisco
Philip Louie, MD
(Spine
Representative)
Spine Surgeon, Department of
Neurosurgery,
Virginia Mason
Medical Center, Seattle,
USA
Chief Operating Officer and
Co-Founder of STREAMD
Prof Matthew Allen, MA, VetMB, PhD
(VET Representative)
Prof of Small Animal Surgery at the University of Cambridge, UK
Find out more
Clinical Evidence
AO ITC clinical research to global standards (ISO 14155 and ICH GCP), drawing on in-house medical and scientific expertise.
Completed studies
We transform ideas into clinical study protocols. AO clinical studies are divided into 5 phases: idea, planning, execution, analysis, and publication.
Clinical Research Fellowship
Apply now to take part in a clinical research fellowship at the AO's Innovation Translation Center.